Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $136.1800 (0.76%) ($134.9900 - $136.2200) on Tue. Sep. 19, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.41% (three month average) | RSI | 81 | Latest Price | $136.1800(0.76%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(56%) IWC(53%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -0.705% in a week (0% probabilities). TLT(-15%) VIXM(-14%) UUP(-8%) GDXJ(-6%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.705% (StdDev 1.41%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $135.85(0.24%) | 10 Day Moving Average | $135.94(0.18%) | 20 Day Moving Average | $131.84(3.29%) | To recent high | -1.3% | To recent low | 17.7% | Market Cap | $2.189b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |